GILEAD SCIENCES, INC. — Director's Dealing 2017

Feb 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-02-15

Reporting Person: Meyers James R (EVP Worldwide Commercial Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-15	Common Stock	A	213	$59.33	Acquired	6939	Direct
2017-02-16	Common Stock	A	1161	—	Acquired	8100	Direct
2017-02-16	Common Stock	A	1022	—	Acquired	9122	Direct
2017-02-16	Common Stock	F	2053	$70.31	Disposed	7069	Direct
2017-02-16	Common Stock	G	4354	—	Disposed	2715	Direct
2017-02-16	Common Stock	G	4354	—	Acquired	125505	Indirect

Footnotes

F1: Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.

F2: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2015, and February 1, 2016. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual satisfies the applicable service-vesting requirements by continuing in the Issuer's employ through December 31, 2017 and December 31, 2018, respectively.

F3: Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2014. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors.

F4: Shares gifted to family trust.